Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. - Wikidata - awgldk - TriplyDB

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

http://www.wikidata.org/entity/Q34491713

about

New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin MicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease Vitamin D status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adults The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study.Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors.Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease.Vitamin D and diabetes mellitus: Causal or casual association?Which vitamin D in CKD-MBD? The time of burning questions.Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions.Effect of paricalcitol on pancreatic oxidative stress, inflammatory markers, and glycemic status in diabetic rats.Evaluation of vitamin D status and its correlation with oxidative stress markers in women with polycystic ovary syndrome.Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.Vitamin D receptor: A novel therapeutic target for kidney diseases.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.Daily intake of vitamin D- or calcium-vitamin D-fortified Persian yogurt drink (doogh) attenuates diabetes-induced oxidative stress: evidence for antioxidative properties of vitamin D.Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients Redox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D

P2860

Q26739475-CC4E599E-2A39-45A6-991A-B237EBF284D6 Q26784321-25085315-7B97-479A-911C-655BA243F167 Q33652408-7DDFC465-7111-4EEF-AE03-6AD071692836 Q33969236-9437C330-0DE8-4A57-A702-D3940FBF890B Q34059805-13CDCD94-E2C9-4D3D-B09C-938A4D3CFA15 Q36189171-F84D048A-AEC7-470A-80DB-C7715087F454 Q37439484-A567828A-1E15-43BD-9078-79D702D7091C Q37553481-E25B1CA0-C726-43C3-9C90-C610B96B23A4 Q38773655-476C5534-5906-4C28-8125-624D8EA848EB Q42562972-C7F51C30-9394-4525-8499-ED7FE63E29E1 Q44125599-B5C77C23-CA2B-4E81-AE43-4FD8EDDA26A7 Q46251808-F75D7A8D-CCC6-4093-A4D4-A174AEBF9840 Q46497245-DAF4A6ED-42B1-47F2-A678-5DCDBCBB89EC Q47137393-B081FB08-74E2-4CF6-9650-8AAFBC354F31 Q48242270-D28D8910-DF7E-4408-8BF4-8B12B89EAD9C Q49985993-51658DF7-AAC4-446A-8E17-7323DC4D9A4E Q50433834-4EAD85B9-FAAC-427F-AAA7-F1C3C1674595 Q50856187-C0AB022B-091F-4660-A573-CB41B4B45176 Q53146106-9FC3BEC1-A3B0-4A12-BE25-580A7DC95062 Q59127057-CB03FE16-18FF-4335-8A6A-C07A31206F8E Q59132558-AC2D2D3E-4AC1-44D7-B25B-CDAD1292D979

P2860

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

http://www.wikidata.org/entity/Q34491713

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@ast

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@en

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@nl

type

label

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@ast

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@en

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@nl

prefLabel

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@ast

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@en

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@nl

P1433

Q34491713-305AE2A6-9DEA-4CF9-99CE-FAC4BCF3F91F

P1476

Q34491713-B36CB22D-71D0-4DAA-9F5D-6BA5AAACF2C5

P2093

Q34491713-27061A5C-D7FD-4E42-9513-E458E025316A

Q34491713-2952D47C-F2D8-4C25-B3DC-2A64F2494EF3

Q34491713-895D57E4-38CD-43A6-AFD4-A320AD9A0B79

Q34491713-AC74076C-ACCA-449B-AFDB-346398A92038

Q34491713-B2A7EBB5-1000-408B-8EC8-4D44AA4080F4

Q34491713-B6CA3B87-646C-4235-BAAA-3E484CB7CE7B

Q34491713-E777E1A6-A8AB-4FD0-B35C-14AF769E572D

P2860

Q34491713-1877E37D-9A02-4868-B45C-2B472CA28250

Q34491713-1CED5DC7-7799-4E8D-9F8B-F8AE2D9E4F1B

Q34491713-2297D083-D7B0-4361-A9A8-05909B71263E

Q34491713-23107F54-3068-4A36-9132-DA2E985DE9D9

Q34491713-253A65AD-3A64-46AB-B20B-1330FEF8803A

Q34491713-32940774-E72D-454F-AC56-24CBF9F03A57

Q34491713-38644AC8-A645-4F51-A101-D0596DA4A21C

Q34491713-43381FFA-2814-4DB3-9765-8166D495EB1E

Q34491713-489821F6-7A86-4AA6-9121-1EB17FB87E1D

Q34491713-499099C7-9D69-4646-87A2-A52E420CAC1C

P304

Q34491713-466DFDB1-3355-4EA5-9942-617D17A706CA

P31

Q34491713-66CFA25C-0077-47A2-8A42-30B56F44A20C

P356

Q34491713-0231A108-AD07-4143-A274-5A6D348F63D5

P478

Q34491713-E2372D73-6AB6-42FF-BEF5-1417884FF80F

P577

Q34491713-F3D2B116-40EE-488E-9AB1-01967504FD6A

P5875

Q34491713-80CB3B5E-E4DF-4390-86AC-62D8F8A56717

P698

Q34491713-572B8AC4-B4DE-4FA8-8C99-A63593102EE0

P932

Q34491713-8C89208D-6C24-4717-8D37-321652D399F2

P356

1471-2369-13-159

P1433

P1476

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

@en

P2093

Angel L M de Francisco

http://www.w3.org/2001/XMLSchema#string

Javier Santos

http://www.w3.org/2001/XMLSchema#string

Manuel Arias

http://www.w3.org/2001/XMLSchema#string

María Jesús Izquierdo

http://www.w3.org/2001/XMLSchema#string

Mónica Cavia

http://www.w3.org/2001/XMLSchema#string

Pedro Abaigar

http://www.w3.org/2001/XMLSchema#string

Pilar Muñiz

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)

Vitamin D deficiency and risk for cardiovascular disease.

Oxidative modification of low-density lipoprotein (LDL) in HD patients: role in electronegative LDL formation.

Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance.

Evaluation of oxidant stress in dialysis patients.

Vitamin D: modulator of the immune system.

Manifestations of oxidant stress in uremia.

Vitamin D and inflammation.

Oxidative modification of proteins during aging.

P304

159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2369-13-159

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233787003

http://www.w3.org/2001/XMLSchema#string

P698

23186077

http://www.w3.org/2001/XMLSchema#string

P932

3520723

http://www.w3.org/2001/XMLSchema#string